Toan Huy Nguyen, Quyet Van Ha, Huong Van Nguyen, Duyet Van Pham, Thuong Van Pham, Thanh Van Le, Xuan Anh Le, Ai Quoc Dang
{"title":"筋膜外肝外和筋膜外肝内蒂联合入路在肝细胞癌肝切除术中的生存结果。","authors":"Toan Huy Nguyen, Quyet Van Ha, Huong Van Nguyen, Duyet Van Pham, Thuong Van Pham, Thanh Van Le, Xuan Anh Le, Ai Quoc Dang","doi":"10.5114/ceh.2022.116156","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study was conducted to evaluate the results of hepatectomy for hepatocellular carcinoma (HCC) by the combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches (Ton That Tung method).</p><p><strong>Material and methods: </strong>A longitudinal follow-up study was conducted on 83 patients undergoing hepatectomy for HCC using the combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches at Nghe An Provincial Hospital from April 2017 to July 2021. Survival analysis was applied.</p><p><strong>Results: </strong>The cumulative overall survival (OS) rates after 1, 2, 3 and 4 years were 88.4%, 76.3%, 69.5% and 56.9%, respectively. The mean OS time was 40.68 ±2.17 months. The 1-, 2-, 3- and 4-year disease-free survival (DFS) rates were 67.1%, 56%, 53.1% and 50%, respectively. The mean DFS time was 32.58 ±2.56 months. Surgical margin > 1 cm was an independent predictor of both overall and disease-free survival (HR = 5.194, 95% CI = 1.467-18,385, <i>p</i> = 0.011 for OS; HR = 2.822, 95% CI = 1.231-6.468, <i>p</i> = 0.014 for DFS).</p><p><strong>Conclusions: </strong>Hepatectomy for HCC by a combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches (Ton That Tung method) is effective and safe, and side effects and complications can be controlled. Patient selection is a key issue and plays a very important role in the outcome of treatment.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"8 2","pages":"147-152"},"PeriodicalIF":1.5000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/cc/CEH-8-47009.PMC9442654.pdf","citationCount":"1","resultStr":"{\"title\":\"Survival outcomes of the combination of extrafascial extrahepatic and extrafascial intrahepatic pedicle approaches in hepatectomy for hepatocellular carcinoma.\",\"authors\":\"Toan Huy Nguyen, Quyet Van Ha, Huong Van Nguyen, Duyet Van Pham, Thuong Van Pham, Thanh Van Le, Xuan Anh Le, Ai Quoc Dang\",\"doi\":\"10.5114/ceh.2022.116156\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study was conducted to evaluate the results of hepatectomy for hepatocellular carcinoma (HCC) by the combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches (Ton That Tung method).</p><p><strong>Material and methods: </strong>A longitudinal follow-up study was conducted on 83 patients undergoing hepatectomy for HCC using the combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches at Nghe An Provincial Hospital from April 2017 to July 2021. Survival analysis was applied.</p><p><strong>Results: </strong>The cumulative overall survival (OS) rates after 1, 2, 3 and 4 years were 88.4%, 76.3%, 69.5% and 56.9%, respectively. The mean OS time was 40.68 ±2.17 months. The 1-, 2-, 3- and 4-year disease-free survival (DFS) rates were 67.1%, 56%, 53.1% and 50%, respectively. The mean DFS time was 32.58 ±2.56 months. Surgical margin > 1 cm was an independent predictor of both overall and disease-free survival (HR = 5.194, 95% CI = 1.467-18,385, <i>p</i> = 0.011 for OS; HR = 2.822, 95% CI = 1.231-6.468, <i>p</i> = 0.014 for DFS).</p><p><strong>Conclusions: </strong>Hepatectomy for HCC by a combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches (Ton That Tung method) is effective and safe, and side effects and complications can be controlled. Patient selection is a key issue and plays a very important role in the outcome of treatment.</p>\",\"PeriodicalId\":10281,\"journal\":{\"name\":\"Clinical and Experimental Hepatology\",\"volume\":\"8 2\",\"pages\":\"147-152\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/cc/CEH-8-47009.PMC9442654.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ceh.2022.116156\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/5/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2022.116156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 1
摘要
简介:本研究旨在评价筋膜外肝外入路(Takasaki法)和筋膜外肝内蒂入路(Ton That Tung法)联合行肝细胞癌(HCC)肝切除术的效果。材料和方法:对2017年4月至2021年7月在义安省医院采用筋膜外肝外(Takasaki法)和筋膜外肝内蒂联合入路行HCC肝切除术的83例患者进行了纵向随访研究。采用生存分析。结果:1年、2年、3年、4年累积总生存率(OS)分别为88.4%、76.3%、69.5%、56.9%。平均OS时间40.68±2.17个月。1年、2年、3年和4年无病生存率(DFS)分别为67.1%、56%、53.1%和50%。平均DFS时间为32.58±2.56个月。手术切缘> 1 cm是总生存率和无病生存率的独立预测因子(HR = 5.194, 95% CI = 1.467- 18385, p = 0.011);DFS的HR = 2.822, 95% CI = 1.231 ~ 6.468, p = 0.014)。结论:经筋膜外肝外入路(Takasaki法)和筋膜外肝内蒂入路(tonthat Tung法)联合行HCC肝切除术有效、安全,副作用及并发症可控。患者选择是一个关键问题,对治疗结果起着非常重要的作用。
Survival outcomes of the combination of extrafascial extrahepatic and extrafascial intrahepatic pedicle approaches in hepatectomy for hepatocellular carcinoma.
Introduction: This study was conducted to evaluate the results of hepatectomy for hepatocellular carcinoma (HCC) by the combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches (Ton That Tung method).
Material and methods: A longitudinal follow-up study was conducted on 83 patients undergoing hepatectomy for HCC using the combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches at Nghe An Provincial Hospital from April 2017 to July 2021. Survival analysis was applied.
Results: The cumulative overall survival (OS) rates after 1, 2, 3 and 4 years were 88.4%, 76.3%, 69.5% and 56.9%, respectively. The mean OS time was 40.68 ±2.17 months. The 1-, 2-, 3- and 4-year disease-free survival (DFS) rates were 67.1%, 56%, 53.1% and 50%, respectively. The mean DFS time was 32.58 ±2.56 months. Surgical margin > 1 cm was an independent predictor of both overall and disease-free survival (HR = 5.194, 95% CI = 1.467-18,385, p = 0.011 for OS; HR = 2.822, 95% CI = 1.231-6.468, p = 0.014 for DFS).
Conclusions: Hepatectomy for HCC by a combination of extrafascial extrahepatic (Takasaki method) and extrafascial intrahepatic pedicle approaches (Ton That Tung method) is effective and safe, and side effects and complications can be controlled. Patient selection is a key issue and plays a very important role in the outcome of treatment.
期刊介绍:
Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.